Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: An Updated Systematic Review and Meta-analysis.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 27327557)

Published in J ECT on December 01, 2016

Authors

Alisson Paulino Trevizol1, Pedro Shiozawa, Ian A Cook, Isa Albuquerque Sato, Caio Barbosa Kaku, Fernanda Bs Guimarães, Perminder Sachdev, Sujit Sarkhel, Quirino Cordeiro

Author Affiliations

1: From the *Interdisciplinary Center for Clinical Neuromodulation, Santa Casa School of Medical Sciences, São Paulo, Brazil; †Neuromodulation Division, Departments of Psychiatry and Bioengineering, University of California, Los Angeles, CA; ‡Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, Australia; and §Institute of Psychiatry, Kolkata, India.

Articles by these authors

(truncated to the top 100)

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34

Brain reserve and dementia: a systematic review. Psychol Med (2005) 3.24

Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry (2012) 2.83

Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology (2013) 2.62

Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry (2002) 2.39

Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety (2012) 2.23

Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evid Based Complement Alternat Med (2007) 2.22

The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage (2004) 2.04

Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study. BMJ (2010) 2.02

Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry (2005) 1.99

Electroconvulsive therapy in Brazil after the "psychiatric reform": a public health problem--example from a university service. J ECT (2012) 1.95

Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriatr Psychiatry (2009) 1.89

Brain reserve and cognitive decline: a non-parametric systematic review. Psychol Med (2006) 1.82

American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry (2007) 1.79

Discrete neuroanatomical networks are associated with specific cognitive abilities in old age. J Neurosci (2011) 1.61

Lifespan mental activity predicts diminished rate of hippocampal atrophy. PLoS One (2008) 1.59

Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord (2007) 1.59

Sex and symmetry differences in hippocampal volumetrics: before and beyond the opening of the crus of the fornix. Hippocampus (2006) 1.59

Treatment-resistant depression: critique of current approaches. Aust N Z J Psychiatry (2008) 1.54

Abnormalities of the fornix in mild cognitive impairment are related to episodic memory loss. J Alzheimers Dis (2012) 1.52

A web-based data management system to improve care for depression in a multicenter clinical trial. Psychiatr Serv (2002) 1.48

Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry (2004) 1.42

Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res (2009) 1.40

Asperger disorder in adults. South Med J (2011) 1.40

Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci (2004) 1.38

Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. J Affect Disord (2006) 1.31

White matter integrity in mild cognitive impairment: a tract-based spatial statistics study. Neuroimage (2010) 1.30

Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. J Clin Psychopharmacol (2010) 1.29

Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev (2009) 1.25

White matter hyperintensities and within-person variability in community-dwelling adults aged 60-64 years. Neuropsychologia (2007) 1.24

Memory training alters hippocampal neurochemistry in healthy elderly. Neuroreport (2003) 1.24

Cognitive generation of affect in bipolar depression: an fMRI study. Eur J Neurosci (2004) 1.21

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res (2009) 1.18

Optimal weights for local multi-atlas fusion using supervised learning and dynamic information (SuperDyn): validation on hippocampus segmentation. Neuroimage (2011) 1.18

Complex mental activity and the aging brain: molecular, cellular and cortical network mechanisms. Brain Res Rev (2007) 1.17

Cognitive lifestyle and long-term risk of dementia and survival after diagnosis in a multicenter population-based cohort. Am J Epidemiol (2011) 1.15

When more is less: associations between corpus callosum size and handedness lateralization. Neuroimage (2010) 1.14

Biomarkers to predict antidepressant response. Curr Psychiatry Rep (2010) 1.14

Assessment of complex mental activity across the lifespan: development of the Lifetime of Experiences Questionnaire (LEQ). Psychol Med (2006) 1.14

Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14

Changing topological patterns in normal aging using large-scale structural networks. Neurobiol Aging (2010) 1.13

A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol (2009) 1.12

Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study. Dement Geriatr Cogn Disord (2009) 1.12

Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement Geriatr Cogn Disord (2011) 1.12

Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav (2011) 1.11

Within-occasion intraindividual variability and preclinical diagnostic status: is intraindividual variability an indicator of mild cognitive impairment? Neuropsychology (2005) 1.10

fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder. Psychiatry Res (2010) 1.10

Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology (2012) 1.10

Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res (2009) 1.09

The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) (2011) 1.09

Do people become more apathetic as they grow older? A longitudinal study in healthy individuals. Int Psychogeriatr (2009) 1.09

The brain reserve hypothesis, brain atrophy and aging. Gerontology (2006) 1.09

Corpus callosum size, reaction time speed and variability in mild cognitive disorders and in a normative sample. Neuropsychologia (2007) 1.07

Cognitive generation of affect in hypomania: an fMRI study. Bipolar Disord (2004) 1.05

Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression. Neurosurg Clin N Am (2011) 1.04

Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol (2004) 1.03

Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol (2009) 1.01

Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke. J Neurol Neurosurg Psychiatry (2012) 1.01

Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry (2006) 1.00

Volumetrics of the caudate nucleus: reliability and validity of a new manual tracing protocol. Psychiatry Res (2008) 0.99

Memory and executive functioning in obsessive-compulsive disorder: a selective review. J Affect Disord (2007) 0.99

Recent rodent models for Alzheimer's disease: clinical implications and basic research. J Neural Transm (Vienna) (2011) 0.99

Clozapine-induced myoclonus: a case study and brief review. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.98

Behavioral and psychological symptoms associated with dementia subtype and severity. Int Psychogeriatr (2009) 0.97

Weekly alcohol consumption, brain atrophy, and white matter hyperintensities in a community-based sample aged 60 to 64 years. Psychosom Med (2006) 0.97

Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry (2006) 0.96

Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study. Aging Cell (2013) 0.96

Internet-delivered cognitive behavioural therapy for depression: a feasibility open trial for older adults. Aust N Z J Psychiatry (2012) 0.96

The association between financial hardship and amygdala and hippocampal volumes: results from the PATH through life project. Soc Cogn Affect Neurosci (2011) 0.95

White matter hyperintensities are an independent predictor of physical decline in community-dwelling older people. Gerontology (2012) 0.95

Candidate-gene approach in posttraumatic stress disorder after urban violence: association analysis of the genes encoding serotonin transporter, dopamine transporter, and BDNF. J Mol Neurosci (2011) 0.94

White matter injury, neural connectivity and the pathophysiology of psychiatric disorders. Dev Neurosci (2002) 0.93

A new paradigm for the prediction of antidepressant treatment response. Dialogues Clin Neurosci (2009) 0.93

Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neurosci Lett (2006) 0.93

Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry (2006) 0.93

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) (2004) 0.93

Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol (2003) 0.92

Characterizing mild cognitive disorders in the young-old over 8 years: prevalence, estimated incidence, stability of diagnosis, and impact on IADLs. Alzheimers Dement (2013) 0.92

"Getting physical": the management of neuropsychiatric disorders using novel physical treatments. Neuropsychiatr Dis Treat (2006) 0.92

Hormone replacement therapy, brain volumes and white matter in postmenopausal women aged 60-64 years. Neuroreport (2006) 0.92

The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci (2013) 0.92

Can transcranial direct current stimulation enhance outcomes from cognitive training? A randomized controlled trial in healthy participants. Int J Neuropsychopharmacol (2013) 0.92

Neuroplasticity in depressed individuals compared with healthy controls. Neuropsychopharmacology (2013) 0.92

TNF-alpha polymorphisms are associated with obsessive-compulsive disorder. Neurosci Lett (2008) 0.91

Brain dysfunction in anorexia nervosa: cause or consequence of under-nutrition? Curr Opin Psychiatry (2011) 0.91

Catechol-O-methyltransferase (COMT) val158met polymorphism as a risk factor for PTSD after urban violence. J Mol Neurosci (2010) 0.91

Savant-like skills exposed in normal people by suppressing the left fronto-temporal lobe. J Integr Neurosci (2003) 0.91

Does lizard tail lacing heighten cannabis addiction? Am J Addict (2010) 0.91

The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci (2010) 0.91

A genome-wide association study of a sustained pattern of antidepressant response. J Psychiatr Res (2013) 0.90

Inhibition of indoleamine 2,3 dioxygenase activity by H2O2. Arch Biochem Biophys (2006) 0.90

Follow-up of mild cognitive impairment and related disorders over four years in adults in their sixties: the PATH Through Life Study. Dement Geriatr Cogn Disord (2008) 0.90

Hippocampal volumes in adults with bipolar disorder. J Neuropsychiatry Clin Neurosci (2010) 0.90

Computer-delivered cognitive behavioural therapy: effective and getting ready for dissemination. F1000 Med Rep (2010) 0.89

Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr (2008) 0.89

Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol (2009) 0.89

A study of hippocampal shape difference between genders by efficient hypothesis test and discriminative deformation. Med Image Comput Comput Assist Interv (2007) 0.89

Structural brain networks and neuropsychiatric disorders. Curr Opin Psychiatry (2011) 0.89

Fronto-extracephalic transcranial direct current stimulation as a treatment for major depression: an open-label pilot study. J Affect Disord (2011) 0.88

Late onset bipolar disorder associated with white matter hyperintensities: a pathophysiological hypothesis. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.88